| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 22.784 | 23.004 | 24.868 | 35.872 | 37.891 | 41.363 | 47.170 | 56.229 | 67.161 | 59.493 |
| Total Income - EUR | 22.784 | 23.004 | 24.868 | 35.872 | 37.891 | 41.363 | 47.172 | 56.229 | 67.255 | 59.493 |
| Total Expenses - EUR | 20.589 | 21.652 | 25.055 | 41.723 | 41.631 | 45.324 | 46.054 | 54.382 | 66.730 | 60.770 |
| Gross Profit/Loss - EUR | 2.195 | 1.352 | -187 | -5.851 | -3.740 | -3.960 | 1.118 | 1.847 | 525 | -1.277 |
| Net Profit/Loss - EUR | 1.511 | 662 | -801 | -6.210 | -4.119 | -4.222 | 646 | 1.296 | -148 | -1.873 |
| Employees | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Epidur Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.503 | 1.421 | 1.331 | 1.243 | 1.155 | 1.071 | 987 | 930 | 865 | 1.580 |
| Current Assets | 11.139 | 11.514 | 12.863 | 10.536 | 10.089 | 7.384 | 8.286 | 9.299 | 5.107 | 8.981 |
| Inventories | 9.566 | 10.083 | 12.204 | 9.408 | 9.179 | 6.730 | 7.540 | 8.810 | 2.728 | 7.693 |
| Receivables | 67 | 66 | 526 | 18 | 17 | 35 | 0 | 0 | 14 | 425 |
| Cash | 1.505 | 1.365 | 132 | 1.111 | 893 | 619 | 746 | 489 | 2.365 | 863 |
| Shareholders Funds | -321 | 344 | -463 | -6.664 | -10.654 | -14.674 | -13.703 | -12.450 | -12.560 | -14.362 |
| Social Capital | 45 | 45 | 44 | 734 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 12.963 | 12.590 | 14.657 | 18.443 | 21.899 | 23.130 | 22.977 | 22.679 | 18.532 | 24.923 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Epidur Srl